Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0REZ stock hub

LON/0REZ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0REZis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0REZ

In the news

Latest news · LON/0REZ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.2

P25 12.9P50 16.9P75 23.5

Trailing P/E31.3

P25 15.9P50 22.9P75 35.8

ROE10.6

P25 -54.2P50 2.1P75 13.7

ROIC6.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0REZ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

SEK

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	UK
Employees	2,295
Employees Change	44%
Employees Change Percent	1.95
Enterprise value	SEK 1.7B
Exchange	London Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	SE0014401378
Last refreshed	2026-05-10
Market cap	SEK 1.4B
Price	SEK 145
Price currency	SEK
Rev Per Employee	360,085.4x
Sector	Healthcare
Sic	3845
Symbol	lon/0REZ
Website	https://www.add.life

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.2%
EV Earnings	38.39x
EV/EBIT	26.25x
EV/EBITDA	13.7x
EV/FCF	21.23x
EV/Sales	2.1x
FCF yield	5.78%
Forward P/E	18.22x
P/B ratio	3.13x
P/E ratio	31.26x
P/S ratio	1.71x
PE Ratio10 Y	50.64x
PE Ratio3 Y	76.71x
PE Ratio5 Y	61.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8%
EBITDA Margin	13.55%
FCF margin	9.89%
Gross margin	38.29%
Gross Profit	SEK 316.4M
Gross Profit Growth	1.56%
Gross Profit Growth Q	-0.1%
Gross Profit Growth3 Y	5.86%
Gross Profit Growth5 Y	13.92%
Net Income	SEK 45.2M
Net Income Growth	83.82%
Net Income Growth Q	6.72%
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Net Income Growth3 Y	9.81%
Net Income Growth5 Y	-3.81%
Pretax Margin	7.54%
Profit Margin	5.47%
Profit Per Employee	SEK 19,695
Profitable Years	13
ROA	4.1
Roa5y	4.61
ROCE	9.33
ROE	10.57
Roe5y	10.6
ROIC	6.33
Roic5y	7.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.41%
Cagr1y	-21.61%
Cagr3y	5.96%
Cagr5y	-7.78%
Div CAGR3	8.55%
Div CAGR5	-6.99%
EPS Growth	84.09
EPS Growth Q	6.5
EPS Growth Quarters	6
EPS Growth Years	2
EPS Growth3 Y	9.88
EPS Growth5 Y	-5.33
FCF Growth	4.26%
FCF Growth Q	-69.89%
FCF Growth3 Y	30.6%
FCF Growth5 Y	0.77%
OCF Growth	1.45%
OCF Growth Q	-56.67%
OCF Growth10 Y	26.71%
OCF Growth3 Y	22.57%
OCF Growth5 Y	3.57%
Revenue Growth	-0.32x
Revenue Growth Q	-2.11x
Revenue Growth Years	12x
Revenue Growth3 Y	5.03x
Revenue Growth5 Y	11.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.82
Assets	SEK 1B
Cash	SEK 61.4M
Current Assets	SEK 353.2M
Current Liabilities	SEK 326.8M
Debt	SEK 383.6M
Debt EBITDA	SEK 3.03
Debt Equity	SEK 0.85
Debt FCF	SEK 4.69
Equity	SEK 450.7M
Interest Coverage	4.54
Liabilities	SEK 584.6M
Long Term Assets	SEK 682.1M
Long Term Liabilities	SEK 257.8M
Net Cash	SEK -322.2M
Net Cash By Market Cap	SEK -22.81
Net Debt EBITDA	SEK 2.88
Net Debt Equity	SEK 0.71
Net Debt FCF	SEK 3.94
Tangible Book Value	SEK -141.7M
Tangible Book Value Per Share	SEK -1.16
WACC	11.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.08
Inventory Turnover	3.76
Net Working Capital	SEK 125.3M
Quick ratio	0.65
Working Capital	SEK 26.3M
Working Capital Turnover	SEK 18.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.07%
Dividend Growth	105.75%
Dividend Growth Years	1%
Dividend per share	SEK 0.12
Dividend Years	10
Dividend Yield	0.08%
Ex Div Date	2026-05-07
Last Dividend	SEK 0.12
Payout Frequency	Annual
Payout Ratio	16.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	540.66%
1Y total return	-21.59%
200-day SMA	165.6
3Y total return	18.98%
50-day SMA	147.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-33.29%
All Time High	390
All Time High Change	-62.82%
All Time High Date	2021-09-17
All Time Low	25.69
All Time Low Change	464.47%
All Time Low Date	2016-04-27
ATR	4.78
Beta	1.7
Ch YTD	-8.02
High	145.8
High52	207.6
High52 Date	2025-10-23
High52ch	-30.15%
Low	140.8
Low52	133
Low52 Date	2026-03-30
Low52ch	9.02%
Ma50ch	-1.6%
Price vs 200-day SMA	-12.42%
RSI	43.89
RSI Monthly	47.6
RSI Weekly	44.82
Sharpe ratio	-0.74x
Sortino ratio	-0.98
Total Return	0.02%
Tr YTD	-7.07
Tr1m	-0.61%
Tr1w	1.88%
Tr3m	-3.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 66.1M
Operating Income Growth	7.09
Operating Income Growth Q	-2.55
Operating Income Growth3 Y	8.81
Operating Income Growth5 Y	-1.5
Operating margin	8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113,283,949%
Net Borrowing	-16,316,760.5
Shares Insiders	6.87%
Shares Institutions	62.32%
Shares Qo Q	-0.43%
Shares Yo Y	0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 81.7M
Average Volume	7,963x
Bv Per Share	3.7
CAPEX	SEK -18.2M
Ch10y	464.5
Ch1m	-1.63
Ch1w	0.83
Ch1y	-22.71
Ch3m	-4.64
Ch3y	16.74
Ch5y	-35.78
Ch6m	-21.55
Change	0.33%
Change From Open	2.98
Close	144.5
Days Gap	-2.57
Depreciation Amortization	45,846,117.4
Dollar Volume	958,885
Earnings Date	2026-07-16
EBIT	SEK 66.1M
EBITDA	SEK 112M
EPS	SEK 0.37
F Score	8
FCF	SEK 81.7M
FCF EV Yield	4.71x
Financing CF	-23,634,050
Fiscal Year End	December
Founded	1,906
Goodwill	438,721,873.3
Graham Number	69.48591
Graham Upside	-52.08
Income Tax	SEK 16.9M
Investing CF	-44,244,215
Is Primary Listing	0
Last Earnings Date	2026-04-01
Last Report Date	2026-03-31
Last Split Date	2020-05-27
Last Split Type	Forward
Lynch Fair Value	SEK 23.19
Lynch Upside	-84
Ma150	162.1
Ma150ch	-10.53%
Ma20	155.1
Ma20ch	-6.49%
Net CF	32,069,099
Next Earnings Date	2026-07-16
Open	140.8
P FCF Ratio	17.29
P OCF Ratio	14.14
Payment Date	2026-05-13
Position In Range	84
Ppne	87,951,318.9
Price Date	2026-05-08
Price EBITDA	SEK 12.62
Relative Volume	0.86x
Revenue	826,396,002x
Tax By Revenue	2.05x
Tax Rate	27.2%
Tr6m	-20.74%
Volume	6,613

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0REZ dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.12 annual per share

Payout ratio

+16.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.0%

1 consecutive years of growth

Total shareholder yield

+0.0%

Next ex-dividend date: 2026-05-07

Performance

LON/0REZ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0REZ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+62.3%

Share of float held by funds and institutions

Insider ownership

+6.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

LON/0REZ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.9

Neutral momentum band

Price vs 200-day MA

-12.4%

50/200-day relationship not available

Beta (5Y)

1.70

More volatile than the market

Sharpe ratio

-0.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0REZ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0REZ stock rating?

lon/0REZ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0REZ analysis?

The full report lives at /stocks/lon/0REZ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0REZ?

The latest report frames lon/0REZ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0REZ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.